M&A announcement
Logotype for CVS Health Corporation

CVS Health (CVS) M&A announcement summary

Event summary combining transcript, slides, and related documents.

Logotype for CVS Health Corporation

M&A announcement summary

4 Nov, 2026

Deal rationale and strategic fit

  • Combine local pharmacy and clinical access with Aetna’s health benefits, financing, provider collaboration and consumer engagement to make care more integrated, accessible and affordable.

  • Use pharmacy and medical data, predictive analytics and clinical programs across in-store, digital and home-based touchpoints to improve engagement, adherence and access to lower-cost care.

  • Target growth in Medicare and Medicaid, better Medicare Advantage and Part D coordination, and expanded value-based care and chronic-condition management.

Financial terms and conditions

  • Aetna shareholders to receive $145 cash and 0.8378 shares per share, implying ~$207 per share; transaction valued at $69B in equity and $77B including assumed debt.

  • At closing, existing shareholders expected to own 78% and Aetna shareholders 22%; TTM Q3 2017 pro forma revenue was $221.4B and adjusted EBITDA $18.5B.

  • Funding sources included $4.1B available cash, $44.8B new debt and $21.0B new equity; $49B of financing commitments, with closing not contingent on financing.

  • Low- to mid-single-digit accretion expected in the second full year after closing, with no meaningful impact in year one.

  • Pro forma leverage expected to reach ~4.6x; repurchases to pause, dividend maintained, and debt paydown targeted to bring leverage to the low-3x range longer term.

Synergies and expected cost savings

  • Target $750M in synergies in the second full year after closing, with greater long-term potential; near-term target primarily reflects cost and care-management savings, with virtually no revenue synergies assumed.

  • Near-term levers include streamlining corporate functions, improving vendor pricing, combining PBM and PDP operations, and improving enterprise dispensing.

  • Medical-cost opportunities include reducing overtreatment and care-delivery failures, shifting care to lower-cost sites, and using MinuteClinic and Coram assets.

  • Existing integrated programs cited 45% higher case-management engagement and $20 PMPM lower total medical costs; chronic-condition savings can reach $117 per member per month.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from CVS Health